Press Resease

Bioburden Testing Market by Product Type (Instrument and Consumables), by Test Type (Anaerobic, Aerobic, Spore, and Fungi), by Application (Sterility Testing, Medical Devices, and Raw Material), and by End-User (Biotechnology, Pharma, and CMO): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 28-Feb-2019 Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-3869 Status : Published

Global bioburden testing market expected to generate around USD 1,285 million by 2025, at a CAGR of around 12.1% between 2019 and 2025. Bioburden testing process involves measuring of viable microorganism on raw materials packaging and medical devices before sterilization.

Description

The report covers a forecast and an analysis of the bioburden testing market on a global and regional level. The study provides historic data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the bioburden testing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the bioburden testing market on a global level.

In order to give the users of this report a comprehensive view of the bioburden testing market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Bioburden Testing Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, R&D, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

The study provides a decisive view of the bioburden testing market by segmenting the market based on product type, application, test type, end-user, and region. All the segments have been analyzed based on present and future trends in the market, which is estimated from 2019 to 2025. By product type, the market is segmented into instrument and consumables. By application, the market includes sterility testing, medical devices, and raw material. By test type, the market is segmented into anaerobic, aerobic, spore, and fungi. By end-user, the market is segmented into biotechnology, pharma, and CMO.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Canada, Germany, France, UK, Brazil, China, Japan, India, and Brazil.

Some key players of the global bioburden testing market are SGS SA, NAMSA, Charles River, WuXi App Tec, bioMérieux S.A., Pacific BioLabs, Nelson Laboratories, LLC, Thermo Fisher Scientific, Becton, Dickinson and Company, and Merck KGaA among others.

This report segments the global bioburden testing market as follows:

Global Bioburden Testing Market: Product Type Analysis

  • Instrument
  • Consumables

Global Bioburden Testing Market: Test Type Analysis

  • Anaerobic
  • Aerobic
  • Spore 
  • Fungi

Global Bioburden Testing Market: Application Analysis

  • Sterility Testing
  • Medical Devices
  • Raw Material

Global Bioburden Testing Market: End-User Analysis

  • Biotechnology
  • Pharma
  • CMO

Global Bioburden Testing Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Bioburden Testing Market, 2016-2025 (USD Million)
    • 2.2. Global Bioburden Testing Market: Snapshot
  •  
  • Chapter 3. Bioburden Testing Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Bioburden Testing market drivers: Impact analysis
      • 3.2.2. Flourishing biopharmaceutical, medical devices industries
      • 3.2.3. Increase in product recalls due to microbial contamination
    • 3.3. Market Restraints
      • 3.3.1. Global Bioburden Testing market restraints: Impact analysis
      • 3.3.2. High cost of laboratory instruments
      • 3.3.3. Tedious procedure
    • 3.4. Opportunities
      • 3.4.1. Increase in R&D investment in life science industry
      • 3.4.2. Increase in healthcare and medical spending
    • 3.5. Porter's Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Product Type
      • 3.6.2. Market attractiveness analysis, by Application
      • 3.6.3. Market attractiveness analysis, by Test Type
      • 3.6.4. Market attractiveness analysis, by End-User
      • 3.6.5. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Bioburden Testing Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Bioburden Testing Market: company market share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. R&D
      • 4.2.5. Regional Expansion
    • 4.3. Price Trend Analysis
    • 4.4. Test Type Portfolio
  •  
  • Chapter 5. Global Bioburden Testing Market - Product Type Analysis
    • 5.1. Global Bioburden Testing Market: Product Type overview
      • 5.1.1. Global Bioburden Testing market revenue share, by Product Type, 2018 and 2025
    • 5.2. Instrument
  •  
  • Chapter 6. Global Instrument Market, 2016-2025 (USD Million)
    • 6.1. Consumables
      • 6.1.1. Global Consumables Market, 2016-2025 (USD Million)
  •  
  • Chapter 7. Global Bioburden Testing Market - Application Analysis
    • 7.1. Global Bioburden Testing: Application overview
      • 7.1.1. Global Bioburden Testing Market revenue share, by Application, 2018 and 2025
    • 7.2. Sterility Testing
      • 7.2.1. Global Sterility Testing Market, 2016-2025 (USD Million)
    • 7.3. Medical Devices
      • 7.3.1. Global Medical Devices Market,2016-2025 (USD Million)
    • 7.4. Raw Material
      • 7.4.1. Global Raw Material Market, 2016-2025 (USD Million)
  •  
  • Chapter 8. Global Bioburden Testing Market - Test Type Analysis
    • 8.1. Global Bioburden Testing market: Test Type overview
      • 8.1.1. Global Bioburden Testing market revenue share, by Test Type, 2018 and 2025
    • 8.2. Anaerobic
      • 8.2.1. Global Anaerobic Market, 2016-2025 (USD Million)
    • 8.3. Aerobic
      • 8.3.1. Global Aerobic Market, 2016-2025 (USD Million)
    • 8.4. Spore
      • 8.4.1. Global Spore Market, 2016-2025(USD Million)
    • 8.5. Fungi
      • 8.5.1. Global Fungi Market, 2016-2025(USD Million)
  •  
  • Chapter 9. Global Bioburden Testing Market - End-User Analysis
    • 9.1. Global Bioburden Testing Market: end-user overview
      • 9.1.1. Global Bioburden Testing Market revenue share, by end-user, 2018 and 2025
    • 9.2. Biotechnology
      • 9.2.1. Global Biotechnology Market, 2016-2025 (USD Million)
    • 9.3. Pharma
      • 9.3.1. Global Pharma Market, 2016-2025 (USD Million)
    • 9.4. CMO
      • 9.4.1. Global CMO Market, 2016-2025 (USD Million)
  •  
  • Chapter 10. Global Bioburden Testing Market - Regional Analysis
    • 10.1. Global Bioburden Testing Market: Regional overview
      • 10.1.1. Global Bioburden Testing Market revenue share, by region, 2018 and 2025
    • 10.2. North America
      • 10.2.1. North America Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
      • 10.2.2. North America Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
      • 10.2.3. North America Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
      • 10.2.4. North America Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
      • 10.2.5. The U.S.
        • 10.2.5.1. The U.S. Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
        • 10.2.5.2. The U.S. Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
        • 10.2.5.3. The U.S. Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
        • 10.2.5.4. The U.S. Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
      • 10.2.6. Rest of North America
        • 10.2.6.1. Rest of North America Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
        • 10.2.6.2. Rest of North America Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
        • 10.2.6.3. Rest of North America Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
        • 10.2.6.4. Rest of North America Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
    • 10.3. Europe
      • 10.3.1. Europe Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
      • 10.3.2. Europe Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
      • 10.3.3. Europe Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
      • 10.3.4. Europe Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
      • 10.3.5. Germany
        • 10.3.5.1. Germany Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
        • 10.3.5.2. Germany Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
        • 10.3.5.3. Germany Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
        • 10.3.5.4. Germany Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
      • 10.3.6. France
        • 10.3.6.1. France Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
        • 10.3.6.2. France Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
        • 10.3.6.3. France Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
        • 10.3.6.4. France Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
      • 10.3.7. UK
        • 10.3.7.1. UK Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
        • 10.3.7.2. UK Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
        • 10.3.7.3. UK Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
        • 10.3.7.4. UK Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
      • 10.3.8. Rest of Europe
        • 10.3.8.1. Rest of Europe Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
        • 10.3.8.2. Rest of Europe Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
        • 10.3.8.3. Rest of Europe Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
        • 10.3.8.4. Rest of Europe Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
    • 10.4. Asia Pacific
      • 10.4.1. Asia Pacific Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
      • 10.4.2. Asia Pacific Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
      • 10.4.3. Asia Pacific Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
      • 10.4.4. Asia Pacific Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
      • 10.4.5. China
        • 10.4.5.1. China Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
        • 10.4.5.2. China Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
        • 10.4.5.3. China Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
        • 10.4.5.4. China Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
      • 10.4.6. Japan
        • 10.4.6.1. Japan Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
        • 10.4.6.2. Japan Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
        • 10.4.6.3. Japan Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
        • 10.4.6.4. Japan Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
      • 10.4.7. India
        • 10.4.7.1. India Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
        • 10.4.7.2. India Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
        • 10.4.7.3. India Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
        • 10.4.7.4. India Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
      • 10.4.8. Rest of Asia Pacific
        • 10.4.8.1. Rest of Asia Pacific Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
        • 10.4.8.2. Rest of Asia Pacific Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
        • 10.4.8.3. Rest of Asia Pacific Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
        • 10.4.8.4. Rest of Asia Pacific Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
    • 10.5. Latin America
      • 10.5.1. Latin America Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
      • 10.5.2. Latin America Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
      • 10.5.3. Latin America Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
      • 10.5.4. Latin America Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
      • 10.5.5. Brazil
        • 10.5.5.1. Brazil Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
        • 10.5.5.2. Brazil Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
        • 10.5.5.3. Brazil Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
        • 10.5.5.4. Brazil Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
      • 10.5.6. Rest of Latin America
        • 10.5.6.1. Rest of Latin America Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
        • 10.5.6.2. Rest of Latin America Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
        • 10.5.6.3. Rest of Latin America Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
        • 10.5.6.4. Rest of Latin America Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
    • 10.6. The Middle East and Africa
      • 10.6.1. The Middle East and Africa Bioburden Testing market revenue, by Product Type, 2016-2025 (USD Million)
      • 10.6.2. The Middle East and Africa Bioburden Testing market revenue, by Application, 2016-2025 (USD Million)
      • 10.6.3. The Middle East and Africa Bioburden Testing market revenue, by Test Type, 2016-2025 (USD Million)
      • 10.6.4. The Middle East and Africa Bioburden Testing market revenue, by End-user, 2016-2025 (USD Million)
  •  
  • Chapter 11. Company Profile
    • 11.1. SGS SA
      • 11.1.1. Overview
      • 11.1.2. Financials
      • 11.1.3. Product Type portfolio
      • 11.1.4. Business strategy
      • 11.1.5. Recent developments
    • 11.2. NAMSA
      • 11.2.1. Overview
      • 11.2.2. Financials
      • 11.2.3. Product Type portfolio
      • 11.2.4. Business strategy
      • 11.2.5. Recent developments
    • 11.3. Charles River
      • 11.3.1. Overview
      • 11.3.2. Financials
      • 11.3.3. Product Type portfolio
      • 11.3.4. Business strategy
      • 11.3.5. Recent developments
    • 11.4. WuXi App Tec
      • 11.4.1. Overview
      • 11.4.2. Financials
      • 11.4.3. Product Type portfolio
      • 11.4.4. Business strategy
      • 11.4.5. Recent developments
    • 11.5. bioMérieux S.A.
      • 11.5.1. Overview
      • 11.5.2. Financials
      • 11.5.3. Product Type portfolio
      • 11.5.4. Business strategy
      • 11.5.5. Recent developments
    • 11.6. Pacific BioLabs
      • 11.6.1. Overview
      • 11.6.2. Financials
      • 11.6.3. Product Type portfolio
      • 11.6.4. Business strategy
      • 11.6.5. Recent developments
    • 11.7. Nelson Laboratories, LLC
      • 11.7.1. Overview
      • 11.7.2. Financials
      • 11.7.3. Product Type portfolio
      • 11.7.4. Business strategy
      • 11.7.5. Recent developments
    • 11.8. Thermo Fisher Scientific, Inc.
      • 11.8.1. Overview
      • 11.8.2. Financials
      • 11.8.3. Product Type portfolio
      • 11.8.4. Business strategy
      • 11.8.5. Recent developments
    • 11.9. Becton, Dickinson, and Company
      • 11.9.1. Overview
      • 11.9.2. Financials
      • 11.9.3. Product Type portfolio
      • 11.9.4. Business strategy
      • 11.9.5. Recent developments
    • 11.10. Merck KGaA
      • 11.10.1. Overview
      • 11.10.2. Financials
      • 11.10.3. Product Type portfolio
      • 11.10.4. Business strategy
      • 11.10.5. Recent developments

Methodology

Free Analysis

Bioburden testing process involves measuring of viable microorganism on raw materials packaging and medical devices. Bioburden testing further helps in finalizing the various parameters for effective sterilization process to ensure safety and efficacy. Bioburden testing is also known as microbial limit testing, which is witnessed across various industries, such as medical devices, pharmaceutical, etc., for quality control purpose. Proper care has to be taken during the testing so as to not introduce any new microorganism to the sample or kill the existing organisms. This can be done via two different methods—Membrane-Filtration Method and Plate Count Method. The bioburden tests can be represented in the colony forming unit and there are established guidelines for the maximum colony forming unit.

There are various major factors driving the global bioburden testing market over the forecast timeframe including the rapid expansion of the biopharmaceutical industry, increasing number of contract research organizations, and flourishing medical device industry. Moreover, the rising number of product recalls from the market due to microbial contamination is also expected to promote bioburden testing market expansion in the future. Furthermore, growing food and beverage safety concerns and supplements are expected to further drive the growth of bioburden testing market over the estimated timeframe. Huge spending on the R&D activities witnessed in the life sciences industry coupled with an increase in medical expenses and improvements made in the healthcare facilities are expected to create numerous growth opportunities in the market in the future. However, the escalating costs of laboratory equipment and the tedious procedure may obstruct the bioburden testing market evolution over the estimated time span.

Global Bioburden Testing Market

The global bioburden testing market is classified into product type, application, test type, and end-user. On the basis of product type, the bioburden testing market is segmented into instrument and consumables. The consumables segment is anticipated to grow rapidly in the future. On the basis of test type, the bioburden testing market is segmented into anaerobic, aerobic, spore, and fungi. Based on application, the bioburden testing market is sectored into sterility testing, medical devices, and raw material. Based on end-user, the market is classified into biotechnology, pharma, and CMO.

By region, North America is predicted to hold a major revenue share of the global bioburden testing market in the future.  This can be attributed to the increasing use of bioburden tests by the biopharmaceutical and healthcare industries, massive support from the government for the establishment of well-developed pharmaceutical industry, and a growing number of research and development facilities. The Asia Pacific Bioburden testing market is anticipated to develop rapidly over the forecast time period owing to the presence of emerging economies, such as China and India. The Latin American and the Middle Eastern and African markets are foreseen to grow moderately in the future.

Some key players of the global bioburden testing market are SGS SA, NAMSA, Charles River, WuXi App Tec, bioMérieux S.A., Pacific BioLabs, Nelson Laboratories, LLC, Thermo Fisher Scientific, Becton, Dickinson and Company, and Merck KGaA among others.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com